Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sameer Bansilal

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
American Heart Journal|September 21, 2015
Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: the Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial)Sameer Bansilal, Zachary Bloomgarden, Jonathan L Halperin, et al.
American Heart Journal|June 15, 2018
The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)-TIMI 58 TrialStephen D Wiviott, Itamar Raz, Marc P Bonaca, et al.
Journal of the American College of Cardiology|November 15, 2019
Different Lifestyle Interventions in Adults From Underserved Communities: The FAMILIA TrialRodrigo Fernandez-Jimenez, Risa Jaslow, Sameer Bansilal, et al.
American Heart Journal|June 5, 2017
Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS studyUsman Baber, Samantha Sartori, Melissa Aquino, et al.
Journal of the American College of Cardiology|November 13, 2015
A Comprehensive Lifestyle Peer Group-Based Intervention on Cardiovascular Risk Factors: The Randomized Controlled Fifty-Fifty ProgramEmilia Gómez-Pardo, Juan Miguel Fernández-Alvira, Marta Vilanova, et al.
The American Journal of Cardiology|May 10, 2015
Balancing the Risk of Bleeding and Stroke in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the AVIATOR Registry)Marco G Mennuni, Jonathan L Halperin, Sameer Bansilal, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 22, 2016
Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS RegistryJaya Chandrasekhar, Sameer Bansilal, Usman Baber, et al.
Journal of the American College of Cardiology|August 20, 2016
Association Between a Social-Business Eating Pattern and Early Asymptomatic AtherosclerosisJosé L Peñalvo, Leticia Fernández-Friera, Beatriz López-Melgar, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 19, 2019
Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromesMichela Faggioni, Usman Baber, Jaya Chandrasekhar, et al.
Journal of the American College of Cardiology|February 7, 2018
Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary DiseaseSameer Bansilal, Marc P Bonaca, Jan H Cornel, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
American Heart Journal|September 21, 2015
Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: the Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial)Sameer Bansilal, Zachary Bloomgarden, Jonathan L Halperin, et al.
American Heart Journal|June 15, 2018
The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)-TIMI 58 TrialStephen D Wiviott, Itamar Raz, Marc P Bonaca, et al.
Journal of the American College of Cardiology|November 15, 2019
Different Lifestyle Interventions in Adults From Underserved Communities: The FAMILIA TrialRodrigo Fernandez-Jimenez, Risa Jaslow, Sameer Bansilal, et al.
American Heart Journal|June 5, 2017
Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS studyUsman Baber, Samantha Sartori, Melissa Aquino, et al.
Journal of the American College of Cardiology|November 13, 2015
A Comprehensive Lifestyle Peer Group-Based Intervention on Cardiovascular Risk Factors: The Randomized Controlled Fifty-Fifty ProgramEmilia Gómez-Pardo, Juan Miguel Fernández-Alvira, Marta Vilanova, et al.
The American Journal of Cardiology|May 10, 2015
Balancing the Risk of Bleeding and Stroke in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the AVIATOR Registry)Marco G Mennuni, Jonathan L Halperin, Sameer Bansilal, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 22, 2016
Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS RegistryJaya Chandrasekhar, Sameer Bansilal, Usman Baber, et al.
Journal of the American College of Cardiology|August 20, 2016
Association Between a Social-Business Eating Pattern and Early Asymptomatic AtherosclerosisJosé L Peñalvo, Leticia Fernández-Friera, Beatriz López-Melgar, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 19, 2019
Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromesMichela Faggioni, Usman Baber, Jaya Chandrasekhar, et al.
Journal of the American College of Cardiology|February 7, 2018
Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary DiseaseSameer Bansilal, Marc P Bonaca, Jan H Cornel, et al.
Pageof 8